Cardio-kidney-metabolic phenotypes determine residual cardiovascular risk after acute coronary syndromes

19 February 2026 (13:30 - 14:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Miss Yifan Wang

University of Zurich, Zurich (Switzerland)

6 More presentations in this session

Presentation thumbnail

Impact of cardio-oncology services on care and outcomes of STEMI patients with active cancer

Doctor M. Dafaalla (Stoke-on-Trent, GB)

Abstract Slides

Presentation thumbnail

Impact of sex on residual angina after percutaneous coronary interventions

Doctor D. Munhoz (Aalst, BE)

Abstract Slides

Presentation thumbnail

Polymer-free amphilimus-eluting stents vs. biodegradable-polymer everolimus-eluting stents in all-comers undergoing pci: 2-year results of the PARTHENOPE trial

Associate Professor R. Piccolo (Naples, IT)

Abstract Slides

Presentation thumbnail

What makes it stentless? Development and internal validation of bailout risk score in DCB-only PCI

Doctor L. Iossa (Mercogliano, IT)

Abstract Slides

Presentation thumbnail

Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in acute coronary syndrome (ACS dragon-registry)

Professor R. Januszek (Krakow, PL)

Abstract Slides

Access the full session

Session thumbnail

Personalised PCI: special populations, innovative devices and tailored therapy

The Event

Event poster

EAPCI Summit 2026

19 February 2026 13:30 CET

You may be interested in

Webinar

Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

Congress Presentation

A patient with coronary artery disease and diabetes: case presentation

Webinar

Chronic coronary syndrome post-myocardial infarction: disease progression and comorbidities

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources